Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells

Carcinogenesis

Volumn 29, Issue 4, 2008, Pages 713-721

  Jung, Seung Nam ^a   Yang, Woo Kyeom ^a   Kim, Joungmok ^a   Kim, Hak Su ^a   Kim, Eun Ju ^a   Yun, Hee ^a   Park, Hyunsung ^b   Kim, Sung Soo ^a   Choe, Wonchae ^a   Kang, Insug ^a   Ha, Joohun ^a  

^a Kyung Hee University Hospital   (South Korea)

^b University of Seoul   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; JANUS KINASE 2; MENADIONE; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CONTROLLED STUDY; GENE TRANSFER; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN DEGRADATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STIMULATION; UBIQUITINATION;

ADENYLATE KINASE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; COLONIC NEOPLASMS; ENZYME ACTIVATION; GENE TRANSFER TECHNIQUES; GENES, MYC; GENES, REPORTER; HELA CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TRANSCRIPTION, GENETIC; UBIQUITIN;

EID: 41849094797     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn032     Document Type: Article

References (44)

1. Pouyssegur,J. et al. (2006) Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature, 441, 437-443.
2. Wang,G.L. et al. (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl Acad. Sci. USA., 92, 5510-5514.
3. Bruick,R.K. et al. (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science, 294, 1337-1340.
4. Berra,E. et al. (2006) The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signalling. EMBO Rep., 7, 41-45.
5. Acker,T. et al. (2006) The good, the bad and the ugly in oxygen-sensing: ROS, cytochromes and prolyl-hydroxylases. Cardiovasc. Res., 71, 195-207.
6. Ivan,M. et al. (2001) HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science, 292, 464-468.
7. Dery,M.A. et al. (2005) Hypoxia-inducible factor 1: Regulation by hypoxic and non-hypoxic activators. Int. J. Biochem. Cell Biol., 37, 535-540.
8. Richard,D.E. et al. (2000) Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J. Biol. Chem., 275, 26765-26771.
9. Gorlach,A. et al. (2001) Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase. Circ. Res., 89, 47-54.
10. Kietzmann,T. et al. (2005) Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin. Cell Dev. Biol., 16, 474-486.
11. Hool,L.C. et al. (2002) Decreasing cellular hydrogen peroxide with catalase mimics the effects of hypoxia on the sensitivity of the L-type Ca2+ channel to beta-adrenergic receptor stimulation in cardiac myocytes. Circ. Res., 91, 601-609.
12. Vaux,E.C. et al. (2001) Regulation of hypoxia-inducible factor is preserved in the absence of a functioning mitochondrial respiratory chain. Blood, 98, 296-302.
13. Kietzmann,T. et al. (1996) Regulation of the gluconeogenic phosphoenolpyruvate carboxykinase and glycolytic aldolase A gene expression by O2 in rat hepatocyte cultures. Involvement of hydrogen peroxide as mediator in the response to O2. FEBS Lett., 388, 228-232.
14. Guzy,R.D. et al. (2005) Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab., 1, 401-408.
15. Chandel,N.S. et al. (2000) Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: A mechanism of O2 sensing. J. Biol. Chem., 275 25130-25138.
16. Huang,L.E. et al. (1996) Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J. Biol. Chem., 271, 32253-32259.
17. Chang,T.C. et al. (2005) Stabilization of hypoxia-inducible factor-1{alpha} by prostacyclin under prolonged hypoxia via reducing reactive oxygen species level in endothelial cells. J. Biol. Chem. 280, 36567-36574.
18. Srinivas,V. et al. (2001) Oxygen sensing and HIF-1 activation does not require an active mitochondrial respiratory chain electron-transfer pathway. J. Biol. Chem., 276, 21995-21998.
19. Kemp,B.E. et al. (2003) AMP-activated protein kinase, super metabolic regulator. Biochem. Soc. Trans., 31, 162-168.
20. Marsin,A.S. et al. (2002) The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase. J. Biol. Chem., 277, 30778-30783.
21. Choi,S.L. et al. (2001) The regulation of AMP-activated protein kinase by H(2)O(2). Biochem. Biophys. Res. Commun., 287, 92-97.
22. Lee,M. et al. (2003) AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells. J. Biol. Chem., 278, 39653-39661.
23. Yun,H. et al. (2005) Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma. J. Biol. Chem., 280, 9963-9972.
24. Lee,M. et al. (2006) Critical roles of AMP-activated protein kinase in the carcinogenic metal-induced expression of VEGF and HIF-1 proteins in DU145 prostate carcinoma. Biochem. Pharmacol., 72 91-103.
25. Watanabe,N. et al. (2003) Autoxidation of extracellular hydroquinones is a causative event for the cytotoxicity of menadione and DMNQ in A549-S cells. Arch. Biochem. Biophys., 411, 145-157.
26. Zhou,G. et al. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest., 108, 1167-1174.
27. Treins,C. et al. (2002) Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J. Biol. Chem., 277, 27975-27981.
28. Gao,N. et al. (2002) p38 Signaling-mediated hypoxia-inducible factor 1alpha and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells. J. Biol. Chem., 277 45041-45048.
29. Hur,E. et al. (2001) Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1alpha. Mol. Pharmacol., 59, 1216-1224.
30. McMahon,S. et al. (2006) Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. J. Biol. Chem., 281, 24171-24181.
31. Gerald,D. et al. (2004) JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell, 118, 781-794.
32. Richard,D.E. et al. (1999) p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J. Biol. Chem., 274, 32631-32637.
33. Mylonis,J. et al. (2006) Identification of MAPK phosphorylation sites and their role in the localization and activity of hypoxia-inducible factor-1alpha. J. Biol. Chem., 281, 33095-33106.
34. Kwon,S.J. et al. (2005) Signal pathway of hypoxia-inducible factor-1alpha phosphorylation and its interaction with von Hippel-Lindau tumor suppressor protein during ischemia in MiaPaCa-2 pancreatic cancer cells. Clin. Cancer Res., 11, 7607-7613.
35. Comerford,K.M. et al. (2004) c-Jun NH2-terminal kinase activation contributes to hypoxia-inducible factor 1alpha-dependent P-glycoprotein expression in hypoxia. Cancer Res., 64, 9057-9061.
36. Mazure,N.M. et al. (1997) Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood, 90, 3322-3331.
37. Jung,J.E. et al. (2005) STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. FASEB J., 19, 1296-1298.
38. Storz,P. (2005) Reactive oxygen species in tumor progression. Front. Biosci., 10, 1881-1896.
39. Behrend,L. et al. (2003) Reactive oxygen species in oncogenic transformation. Biochem. Soc. Trans., 31, 1441-1444.
40. Zhou,Q. et al. (2007) Reactive oxygen species regulate insulin-induced VEGF and HIF-1alpha expression through the activation of p70S6K1 in human prostate cancer cells. Carcinogenesis, 28, 28-37.
41. Page,E.L. et al. (2002) Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J. Biol. Chem., 277, 48403-48409.
42. Pan,Y. et al. (2007) Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. Mol. Cell. Biol., 27, 912-925.
43. King,A. et al. (2006) Succinate dehydrogenase and fumarate hydratase: Linking mitochondrial dysfunction and cancer. Oncogene, 25, 4675-4682.
44. Hergovich,A. et al. (2006) Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3. Mol. Cell. Biol., 26, 5784-5796.